This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Years ago, Robyn Munsch would wander hungrily around the grocery store and leave with calorie-dense foods like a frozen pizza ...

Eli Lilly (LLY) is scheduled to release its Q1 earnings on May 1, and analysts continue to stay positive, holding onto Buy ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

Healthcare in the U.S. is expensive, there's no doubt about that. In fact, the Peter G. Peterson Foundation found that the ...

The first step of setting up a new device starts with cleaning up your old phone. If you’re planning on trading in your old ...

Kristen Gryskevich, 51, found weight to be a struggle throughout her life, but when she gave birth to her two boys in 2001 ...

In July 2024, just eight of the strategy’s 90 holdings were not in the index, but those included recent darlings such as social media giant Meta Platforms and Eli Lilly, maker of GLP-1 drug ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

A federal judge's ruling essentially blocks compound pharmacies from selling less-expensive, unapproved versions of Ozempic ...

What happens to your body after you stop taking Ozempic has been revealed, after the use of weight loss medications has ...